Roche to park $50B in U.S. over five years, create 12,000 jobs

 Swiss pharma giant Roche (OTCQX:RHHBY) (OTCQX:RHHBF) will invest $50B in the U.S. over the next five years in an attempt to avoid President Trump's tariffs.

This substantial investment aims to expand, upgrade its manufacturing and R&D facilities across multiple states, including Kentucky, Indiana, New Jersey, Oregon, California, Pennsylvania, and Massachusetts.

The investments are expected to create more than 12,000 new jobs, including nearly 6,500 construction jobs, as well as 1,000 jobs at new and expanded facilities.

The company said that, once all new and expanded manufacturing capacity comes on-line, it will export more medicines from the U.S. than it imports.

Additionally, it will build a manufacturing plant to support the expansion of next-generation weight loss medicines, though it didn’t disclose the location of the facility.

"Our investments of $50 billion over the next five years will lay the foundation for our next era of innovation and growth, benefiting patients in the U.S. and around the world," said CEO Thomas Schinecker.

https://www.msn.com/en-us/money/markets/roche-to-park-50b-in-u-s-over-five-years-create-12-000-jobs/ar-AA1DmH1L